Literature DB >> 28966146

Understanding gene functions and disease mechanisms: Phenotyping pipelines in the German Mouse Clinic.

Helmut Fuchs1, Juan Antonio Aguilar-Pimentel1, Oana V Amarie2, Lore Becker1, Julia Calzada-Wack1, Yi-Li Cho1, Lillian Garrett2, Sabine M Hölter2, Martin Irmler1, Martin Kistler1, Markus Kraiger1, Philipp Mayer-Kuckuk1, Kristin Moreth1, Birgit Rathkolb3, Jan Rozman4, Patricia da Silva Buttkus1, Irina Treise1, Annemarie Zimprich2, Kristine Gampe1, Christine Hutterer1, Claudia Stöger1, Stefanie Leuchtenberger1, Holger Maier1, Manuel Miller5, Angelika Scheideler5, Moya Wu1, Johannes Beckers6, Raffi Bekeredjian7, Markus Brielmeier5, Dirk H Busch8, Martin Klingenspor9, Thomas Klopstock10, Markus Ollert11, Carsten Schmidt-Weber12, Tobias Stöger13, Eckhard Wolf14, Wolfgang Wurst15, Ali Önder Yildirim13, Andreas Zimmer16, Valérie Gailus-Durner1, Martin Hrabě de Angelis17.   

Abstract

Since decades, model organisms have provided an important approach for understanding the mechanistic basis of human diseases. The German Mouse Clinic (GMC) was the first phenotyping facility that established a collaboration-based platform for phenotype characterization of mouse lines. In order to address individual projects by a tailor-made phenotyping strategy, the GMC advanced in developing a series of pipelines with tests for the analysis of specific disease areas. For a general broad analysis, there is a screening pipeline that covers the key parameters for the most relevant disease areas. For hypothesis-driven phenotypic analyses, there are thirteen additional pipelines with focus on neurological and behavioral disorders, metabolic dysfunction, respiratory system malfunctions, immune-system disorders and imaging techniques. In this article, we give an overview of the pipelines and describe the scientific rationale behind the different test combinations.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene function analysis; Mouse model; Mouse phenotyping; Phenotyping pipeline

Mesh:

Year:  2017        PMID: 28966146     DOI: 10.1016/j.bbr.2017.09.048

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

Review 1.  Biologia futura: animal testing in drug development-the past, the present and the future.

Authors:  Miklós Sántha
Journal:  Biol Futur       Date:  2020-10-21

Review 2.  Recommended housing densities for research mice: filling the gap in data-driven alternatives.

Authors:  Karen L Svenson; Beverly Paigen
Journal:  FASEB J       Date:  2018-12-06       Impact factor: 5.834

3.  Claudin-12 is not required for blood-brain barrier tight junction function.

Authors:  Mariana Castro Dias; Caroline Coisne; Pascale Baden; Gaby Enzmann; Lillian Garrett; Lore Becker; Sabine M Hölter; Martin Hrabě de Angelis; Urban Deutsch; Britta Engelhardt
Journal:  Fluids Barriers CNS       Date:  2019-09-12

4.  Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model.

Authors:  Eva Auffenberg; Ulrike Bs Hedrich; Raffaella Barbieri; Daniela Miely; Bernhard Groschup; Thomas V Wuttke; Niklas Vogel; Philipp Lührs; Ilaria Zanardi; Sara Bertelli; Nadine Spielmann; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Michael Pusch; Martin Dichgans; Holger Lerche; Paola Gavazzo; Nikolaus Plesnila; Tobias Freilinger
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

5.  Post-synaptic scaffold protein TANC2 in psychiatric and somatic disease risk.

Authors:  Lillian Garrett; Patricia Da Silva-Buttkus; Birgit Rathkolb; Raffaele Gerlini; Lore Becker; Adrian Sanz-Moreno; Claudia Seisenberger; Annemarie Zimprich; Antonio Aguilar-Pimentel; Oana V Amarie; Yi-Li Cho; Markus Kraiger; Nadine Spielmann; Julia Calzada-Wack; Susan Marschall; Dirk Busch; Carsten Schmitt-Weber; Eckhard Wolf; Wolfgang Wurst; Helmut Fuchs; Valerie Gailus-Durner; Sabine M Hölter; Martin Hrabě de Angelis
Journal:  Dis Model Mech       Date:  2022-03-04       Impact factor: 5.758

6.  Mice lacking the mitochondrial exonuclease MGME1 develop inflammatory kidney disease with glomerular dysfunction.

Authors:  Dusanka Milenkovic; Adrián Sanz-Moreno; Julia Calzada-Wack; Birgit Rathkolb; Oana Veronica Amarie; Raffaele Gerlini; Antonio Aguilar-Pimentel; Jelena Misic; Marie-Lune Simard; Eckhard Wolf; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Nils-Göran Larsson
Journal:  PLoS Genet       Date:  2022-05-09       Impact factor: 6.020

7.  The rRNA m6A methyltransferase METTL5 is involved in pluripotency and developmental programs.

Authors:  Valentina V Ignatova; Paul Stolz; Steffen Kaiser; Tobias H Gustafsson; Palma Rico Lastres; Adrián Sanz-Moreno; Yi-Li Cho; Oana V Amarie; Antonio Aguilar-Pimentel; Tanja Klein-Rodewald; Julia Calzada-Wack; Lore Becker; Susan Marschall; Markus Kraiger; Lillian Garrett; Claudia Seisenberger; Sabine M Hölter; Kayla Borland; Erik Van De Logt; Pascal W T C Jansen; Marijke P Baltissen; Magdalena Valenta; Michiel Vermeulen; Wolfgang Wurst; Valerie Gailus-Durner; Helmut Fuchs; Martin Hrabe de Angelis; Oliver J Rando; Stefanie M Kellner; Sebastian Bultmann; Robert Schneider
Journal:  Genes Dev       Date:  2020-03-26       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.